These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15911861)

  • 21. A rock and a hard place: The selective serotonin reuptake inhibitor dilemmas in addressing perinatal mood and anxiety disorders.
    Stohl H; Kohm AD; Dossett E
    J Neonatal Perinatal Med; 2016; 9(1):1-5. PubMed ID: 27002264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Findings from selective serotonin reuptake inhibitor-exposed neonates should be interpreted with caution.
    Norton JD; Worley LL; Lowery CL
    Pediatrics; 2004 Dec; 114(6):1739-40; author reply 1740-1. PubMed ID: 15574649
    [No Abstract]   [Full Text] [Related]  

  • 23. SSRI antidepressants and persistent pulmonary hypertension in newborns.
    Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient neonatal jitteriness due to maternal use of sertraline (Zoloft).
    Santos RP; Pergolizzi JJ
    J Perinatol; 2004 Jun; 24(6):392-4. PubMed ID: 15167880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
    Cantor Sackett J; Weller RA; Weller EB
    Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [SSRIs and pregnancy: a review of the literature].
    Soufia M; Aoun J; Gorsane MA; Krebs MO
    Encephale; 2010 Dec; 36(6):513-6. PubMed ID: 21130237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.
    Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C
    Arch Gen Psychiatry; 2006 Aug; 63(8):898-906. PubMed ID: 16894066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
    Alwan S; Bandoli G; Chambers CD
    Clin Pharmacol Ther; 2016 Jul; 100(1):34-41. PubMed ID: 27060574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R; Bar-Oz B; Gorelik E; Reif S; Perlman A; Matok I
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E; Carceller AM; Agogué C; Martin BZ; St-André M; Francoeur D; Bérard A
    Pediatrics; 2007 Jan; 119(1):52-9. PubMed ID: 17200271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of selective serotonin reuptake inhibitors during pregnancy and lactation: current knowledge.
    Jerome L
    Can J Psychiatry; 2000 Dec; 45(10):940. PubMed ID: 11190371
    [No Abstract]   [Full Text] [Related]  

  • 33. Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy.
    Bot P; Semmekrot BA; van der Stappen J
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F153. PubMed ID: 16492956
    [No Abstract]   [Full Text] [Related]  

  • 34. SSRIs and birth defects.
    Kelly MB; Wisner KL; Cornelius MD
    Epidemiology; 2007 May; 18(3):411-2; author reply 412-3. PubMed ID: 17435454
    [No Abstract]   [Full Text] [Related]  

  • 35. Neonatal adverse reactions after in utero exposure to selective serotonin reuptake inhibitors: still controversial.
    Beaulac-Baillargeon L; Boucher N
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):855-6; author reply 856. PubMed ID: 16894088
    [No Abstract]   [Full Text] [Related]  

  • 36. Perinatal outcome following third trimester exposure to paroxetine.
    Costei AM; Kozer E; Ho T; Ito S; Koren G
    Arch Pediatr Adolesc Med; 2002 Nov; 156(11):1129-32. PubMed ID: 12413342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent pulmonary hypertension of the newborn and maternal use of SSRIs.
    Wooltorton E
    CMAJ; 2006 May; 174(11):1555-6. PubMed ID: 16670395
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of perinatal exposures on the infant: antidepressants and depression.
    Hanley GE; Oberlander TF
    Best Pract Res Clin Obstet Gynaecol; 2014 Jan; 28(1):37-48. PubMed ID: 24100223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children.
    Boukhris T; Sheehy O; Mottron L; Bérard A
    JAMA Pediatr; 2016 Feb; 170(2):117-24. PubMed ID: 26660917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of antidepressants during pregnancy].
    Pedersen LH; Videbech P
    Ugeskr Laeger; 2011 Apr; 173(15):1118-20. PubMed ID: 21672461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.